chrisvoncsefalvay/vaers-outcomes huggingface dataset:
gave me only .25 ml for my second dose; This spontaneous case was reported by an other health care professional and describes the occurrence of UNDERDOSE (gave me only .25 ml for my second dose) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On an unknown date, the patient experienced UNDERDOSE (gave me only .25 ml for my second dose). At the time of the report, UNDERDOSE (gave me only .25 ml for my second dose) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No Concomitant product use was reported.  It was reported that the patient received only .25 ml for their second dose.   No treatment information was provided.
Nauseas and diaphoretic. water and OJ provided .Denies tingling, SOB,BP 101/69, EMS notified MAP of 61 systolic 77 multiple low BP. EMS arrived 1415 evaluated MAP 70 SBP 99 no orthos done since he was Hypotensive was taken to ER.
3/10/09 - AM shaking arm when reaching, falling over after waking in am by 3/16/09 condition in am + pm - falling over, trouble balancing 3/19 - not able to walk w/out holding our hand sensitive to height change 3/22/09 - Vomiting 1 X daily until 3/27 then sick all day 3/29/09- ER visit for vomiting & dehydration - received 20 fran As of 4/25/09 sick on and off and cannot walk normally/balance issues - lazy speech
a painful lump that appears to be swollen; sore arm; sick a little bit; underarm was swelling/lump in underarm; This is a spontaneous report from a contactable consumer (Patient). A 51-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Formulation: Solution for injection, Lot number and expiration date was not reported), via an unspecified route of administration in right arm on 20May2021 as dose 1, single for COVID-19 immunization. Medical history was none. The patient's concomitant medications were not reported. The patient did not received any other vaccine on same day or within four weeks prior to the first administration date of the suspect vaccine. Patient had no problems with vaccines in past. Family medical history relevant to AEwas none. The patient experienced a painful lump that appears to be swollen in which the lump was "very very obvious.", sore arm, sick a little bit, underarm was swelling/lump in underarm, swollen under the right arm where she got the vaccine on an unspecified date in May2021. It was reported that, patient received the first COVID vaccine last Thursday and she was told that it would be sore and she would be sick a little bit and experienced both and that was okay. 2 days after getting it her underarm was swelling in the same arm she got the vaccine and she felt pain and a lump in the underarm. Went to touch it and it was swollen under the right arm where she got the vaccine. She got it in the right arm since she was left handed. It was so weird and had not experienced any side effects like this before. Patient wanted to know what could she do about the pain and swelling and was this normal side effects she had since this was 2 days after the vaccine. Patient was unable to provide primary care provider. Got the first dose on 20May2021. Again mentioned felt the swelling in the underarm 2 days after getting it. She could feel the lump when she pushes one part of the underarm and saw a lump underneath it. She was scheduled for the second dose in 3 weeks. Patient reported that, she was super healthy person and had no problems. Did not even took any medication for headaches or anything, not even Motrin. No further details provided. The outcome of the events was not resolved.  Information on the lot/batch number has been requested.
received 2 doses of Prevnar 20 within 24 hours; Drug(s) Information Characterization of drug role: Suspect Proprietary medicinal product name: Prevnar 20    Active Substance Information Active Drug substance names: pneumococcal 20-valent conjugate vaccine  Narrative case summary and further information: Case narrative: Originating AE Request: REQ-885366  Attachments: 1 Patient Age: 82 years of age  Reporter Subtype: Pharmacist  PQC Present: No  AE Present: Yes   Request Name: REQ-885366 Product: Prevnar 20  Question: Caller is calling from a Nursing Home. She mentioned one of the residents received 2 doses of Prevnar 20 within 24 hours.  Caller asked if they should "watch for anything specific" and to report this event.  Patient is a female with birthday (DOB withheld).  AE e-transmitted. Caller was transferred to (Name withheld). REPORTUM GMCU0IBP. No NTID was provided.   No follow-up attempts are needed; information about lot/batch number cannot be obtained. No further information is expected.
Allergic reaction to the Fluarix QIV vaccine; This case was reported by a other health professional via call center representative and described the occurrence of allergic reaction in a patient who received Flu Seasonal QIV Dresden (Influenza vaccine Quadrivalent unspecified season) for prophylaxis.   On an unknown date, the patient received Influenza vaccine Quadrivalent unspecified season. On an unknown date, unknown after receiving Influenza vaccine Quadrivalent unspecified season, the patient experienced allergic reaction. On an unknown date, the outcome of the allergic reaction was unknown.   It was unknown if the reporter considered the allergic reaction to be related to Influenza vaccine Quadrivalent unspecified season.   Additional details were reported as follows: The health care professional reported that patient had suffered an allergic reaction to the administration of the vaccine. The health care professional had few information regarding the matter due to the fact that the event happened in another facility from where she was working.  No further events were reported.  The health care professional agreed to be contacted for follow-up. The reporter consented for follow-up.
27yo male vaccinated with Janssen covid vaccine. Within minutes of standing up from vaccination in the vaccine booth, stated he was dizzy. I sat him down immediately, he was having trouble staying awake eyes glossing over, speech very slow. I turned to push the door open into the main pharmacy to call for help and have them dial 911, grabbed epinephrine and ammonia salts as well. When I turned back he had slumped in his chair. As I took the step back towards him, he spontaneously started to sit up and speak. Was diaphoretic, still slow speech eyes glossy. I supported him as best I could. His HR was 42, i lifted his legs up unto to a chair in quazi trandelenburg position. He stated that made him feel alot better. I stayed with him until EMTS arrived. He got himself onto they stretcher and they took him out of the store.
shingles; pain in left arm; This case was reported by a pharmacist via call center representative and described the occurrence of shingles in a male patient who received Herpes zoster (Shingrix) (batch number Ms5hc, expiry date 8th July 2023) for prophylaxis.   On 2nd August 2022, the patient received the 1st dose of Shingrix (intramuscular) .5 ml. In August 2022, 4 days after receiving Shingrix, the patient experienced shingles and pain in arm. On an unknown date, the outcome of the shingles and pain in arm were not recovered/not resolved.   It was unknown if the reporter considered the shingles and pain in arm to be related to Shingrix.     Additional Information: GSK Receipt Date: 05-Oct-2022 Reporter's comment: The pharmacist reported an adverse event for Shingrix. The patient received the first shot of Shingrix. The pharmacist stated that the patient experienced with pain in left arm about 4 days after the vaccination.  The patient went to the physician and they said he had shingles.  The patient still reports pain in the left arm.  The pharmacist was not sure if the patient had lesions or just pain with the Shingles.  The reporter did not consent to follow-up. Less than 2 months,the patient experienced shingles.
Was diagnosed with Bells Palsy which  started on 3/5/21 and affects the left side of my face, slight loss of function of lip and corner of mouth and some sensitivity on left side of my face
headache; nausea; fatigue; site injection pain, red and swollen; site injection pain, red and swollen; site injection pain, red and swollen; This is a spontaneous report from a contactable healthcare professional (patient). A 25-year-old female patient received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EK9231 and expiry date unknown), intramuscular on the left arm on 12Jan2021 15:30 at a single dose for COVID-19 immunization. Medical history included polycystic ovarian syndrome. Concomitant medications included metformin, vitamin D [vitamin D NOS], and unspecified birth control. Patient is not pregnant at the time of vaccination. Patient has no allergies to medications, food, or other products. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Patient was not diagnosed with COVID-19 prior to vaccination. Patient has not been tested for COVID-19 since the vaccination. On 14Jan2021, the patient experienced headache, nausea, fatigue, injection site pain, red and swollen. Outcome of the events was recovered with sequelae. The events were reported as non-serious. No treatment was received for the adverse events.
fainting episode, dizziness, BP dec 90/62;vomiting p/vax;
parents of pt notified office that 9SEP98 pt cried on & off all day & noc & evening of 10SEP98;APAP improved pt disposition;
A few minutes after vaccination, the patient began what appeared to be vasovagal syncope. Symptoms lasted for 1-2 minutes, and the patient awake from syncope and was alert and coherent. Patient felt flush and was sweating. She reported feeling completely normal approximately 5-10 minutes after awakening. Patient did not fall on the ground. She was sitting in a chair and dropped a few items from her hand and slumped into chair for entirety of symptoms. Patient reported no prior issues with vaccinations. Patient came with a friend/family member who was with her during the entirety of symptoms. Patient reported feeling anxious prior to vaccination. Patient also reported that she had nothing to eat prior to vaccination due to nervousness.
Mid right leg has area of erythema and is painful for child since yesterday. NR activity, no fussiness. 15x6cm area of redness, little swelling central area of 3cm purplish coloring.
Pt began to feel light headed and began to vomit. Pt was taken back to a pt room were vital were taken which were normal. Pt began to feel normal again after about 15 minutes.
MODERNA COVID VACCINE #3 GIVEN 9/29/21, LOT #014F21A; 3/9/22 pt transferred to this hosp from outside hospital (name not known) intubated due to hypoxemia; ARF,; hyperkalemia; pt had a positive COVID test 1/23/22; pt still positive for COVID on 3/9/22; critically ill; no improvement; worsened condition; developed A Fib and was treated with medication; pt made a DNR and comfort care; pt expired in the hospital
Patient called on 8/21/12 c/o hives and itching s/p VARIVAX on 8/14/12. Seen in office on 8/22/12 for evaluation. Seen by PA for evaluation. Labs ordered.
Coughing, diffuse itching and feeling of tightness in chest. Started at 7:15 pm and was persistent.
Weakness; chills; fever; headache; muscle ache; extreme body exausion/ Fatigue and exhaustion; This spontaneous case was reported by a health care professional and describes the occurrence of ASTHENIA (Weakness), CHILLS (chills), PYREXIA (fever), HEADACHE (headache) and MYALGIA (muscle ache) in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 prophylaxis. The occurrence of additional non-serious events is detailed below.    Co-suspect product included non-company product TOZINAMERAN (PFIZER BIONTECH COVID-19 VACCINE) for an unknown indication.    No Medical History information was reported.   On 21-May-2021, the patient started TOZINAMERAN (PFIZER BIONTECH COVID-19 VACCINE) (unknown route) 1 dosage form. On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 22-May-2021, the patient experienced ASTHENIA (Weakness), CHILLS (chills), PYREXIA (fever), HEADACHE (headache), MYALGIA (muscle ache) and FATIGUE (extreme body exausion/ Fatigue and exhaustion). On 24-May-2021 at 7:00 AM, ASTHENIA (Weakness), CHILLS (chills), PYREXIA (fever), HEADACHE (headache), MYALGIA (muscle ache) and FATIGUE (extreme body exausion/ Fatigue and exhaustion) had resolved.      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route), the reporter did not provide any causality assessments.   This case was identified as part of a retrospective clean-up activity where certain emails received in the Moderna mailbox were missed to be booked-in.  Concomitant medication was not provided.  No information regarding treatment medication was provided.
Patient reports that day after receiving vaccine her arm was swollen, tender, and had a noticeable knot. Mother called to reported to Health Dept on 12/13/16. Instructed mom to take to doctor.
I did not have any immediate reaction but about 1-2 wks after receiving the shot, all my joints started to ache.  The worst is my hands, shoulders and knees. My hands ache all the time and is hard to make a fist motion.  My shoulders also are achey all the time and I have a hard time lifting my arms up.  My knees more of a discomfort most times and hurt when walking down steps.
3 days after Moderna booster, patient developed painful diplopia due to right sixth nerve palsy
Sore arm - muscle just below injection site when raising arm.  Started within couple hours after injection, continues into day  2. Ongoing  Extreme fatigue  - slept for ~12 hours within an hour of onset of sore arm.  Continued fatigue into day 2.  Overall lack of energy and tire easily. Ongoing
The pt experienced left small finger and ring finger paresthesia, reported one week after 6th anthrax vaccine.  Follow up on 12/20/2000: "Patient recovered partially.  Numbness in ring and fifth finger of left hand.  Numbness is subsiding.  Patient didn't receive any further shots since reported event.  Large knot and soreness followed by numbness in edge of hand fifth and 4th finger."
Started out with her ears ringing 24hrs after taking the vaccine. After that felt like her ears was clogged and the dr stated that it was alot of fluid in both ears. Her lymph has became swollen as well.
Very sore arm after 24 hours, fever and headache. After 48 hours, patient states that soreness went away , but when she tries   to lift arm above shoulder still has pain. Has not seeked any treatment or otc medication use.
Information has been received from a physician concerning an 11 month old (currently 16 month old) male with a history of diaper rash who on 19-NOV-2008 was vaccinated with a third dose of ROTATEQ vaccine (lot # not reported). It was reported that the patient received the vaccination while he was greater than 32 weeks old. It was unknown if there was any relevant laboratory data. As of 13-APR-2009 it was unknown if the child will continue to receive ROTATEQ vaccine and it was unknown if he was experiencing any adverse reactions. Additional information has been requested.
pt recvd fluv vax & 2 wks later pt suffered myocardial infarction w/subsequent development of ventricular fibrillation; pt required mechanical ventilation for approx 10 days;
Patient stated that she is having severe upper right arm pain since receiving the pneumovax 23 vaccine. She has limited arm movement and can not lift her arm past her shoulders. Other  immediate reaction she had after the injection  was swelling and itching which has then gone away. The upper arm pain however, still persist 3 months after the vaccine was administered. Her quality of life has been affected by her inability to sleep comfortably or lay down on her right side due to the pain.
dose too soon; no specific ADR Narrative:  Patient received two Moderna COVID-19 doses within 23 days. No ADRs noted with early administration. Unclear from chart review why dose was administered early.
Pt has tenderness and difficulty lifting arm after shot was given. Symptoms last until 10/10/19
appx 12 hours after receiving her first Moderna Covid19 vaccine, She developed a red itchy hives like rash across her torso that spread over her entire body within 2-3 hours, at which point she took two oral antihistamines (Loratadine) and applied some topical hydrocortisone cream to her body. The scary rash subsided overnight (a week ago) and she hasn't experienced any further reaction.
Major upset stomach and constipation.  Difficulty sleeping. Uncomfortableness throughout the day.
Information has been received from a nurse practitioner concerning a 9 year old male patient with no drug reactions or allergies and no pertinent medical history who on 23-SEP-2005 was vaccinated SQ with a first 0.5ml dose of MMR II (Lot# not reported), and on 06-OCT-2010 was vaccinated SQ with a second 0.5 ml dose of MMR II (Lot# 667729/04917Z, Exp date 06-APR-2012). Suspect secondary therapy included VARIVAX (MSD) (lot # not reported) administered on 06-OCT-2010. The nurse stated that on 07-OCT-2010 the patient complained of not hearing from one ear after receiving the second dose of MMR II. The nurse also stated that the patient had been playing football at that time. At the time of the report the patient's outcome was unknown. The patient sought unspecified medical attention. Upon internal review not hearing from one ear was considered to be an other important medical event. This is an amended report. Primary therapy was changed to VARIVAX. Additional information has been requested.
incapacitating arthralgia and myalgia along with dizziness, headache, and nausea.
was cut by broken glass from the syringe/ her cut finger; there is a half of the end piece of the syringe by the finger flanges missing/ broken syringe; This spontaneous report was received from a medical assistant who was reporting on herself. The medical assistant was a 25-year-old female with no pertinent medical history, concurrent conditions, concomitant medications or known drug reactions and allergies. On 25-NOV-2019, the assistant was administering a dose of hepatitis a vaccine, inactivated (VAQTA) (0,5 ml, lot # S010727 with the expiration date of 26-JUL-2020) to an unspecified patient, and was cut by a broken glass from the syringe. After administration, she noticed there was a half of the end piece of the syringe by the finger flangers missing. The syringe was mostly intact, only two small pieces of glass were missing from the top by the finger flangers.  The medical assistant reported the event resolved on 25-NOV-2019. The causality assessment between the event and hepatitis a vaccine, inactivated (VAQTA) was not provided.
Large (bigger than a golf ball) lump in my left breast; Lump in her left breast, hot to the touch; Lump in my left breast, hot to the touch ,red; Lump in my left breast, hot to the touch ,red, painful; Menstrual period every two weeks since vaccination; This is a spontaneous report from a contactable consumer (patient). A 45-years-old non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot Number: EW0176), dose 2 via an unspecified route of administration, administered in arm left on 08May2021 15:00 (at the age of 45-years-old) as DOSE 2, SINGLE for covid-19 immunisation. The patient medical history and concomitant medications were not reported. Previously, the patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot Number: Er8731), dose 1 via an unspecified route of administration, administered in arm left on 17Apr2021, 15:00 (at the age of 45-years-old) as DOSE 1, SINGLE for covid-19 immunisation. No other vaccine in four weeks. No covid prior vaccination and no covid tested post vaccination. On 12May2021, the patient experienced large (bigger than a golf ball) lump in her left breast, hot to the touch, red, painful for a week. Now in 2021, had a smaller sore lump and menstrual period every two weeks since vaccination. No treatment was received for the events. Outcome of all events was not recovered.    Follow-up attempts are completed. No further information is expected.
Information has been received from a health care professional concerning a 61 year old female physician with no medical history and no allergies or drug reactions who on 02-OCT-2006 was vaccinated intramuscularly in the left arm with a 0.5 ml dose of Pneumovax 23 (lot #651400/0618F). There was no illness at the time of vaccination. That same day at 1750 the patient experienced pain, redness and swelling at, and around the injection site, and felt sick and run down. The redness went around the entire left arm. The patient felt the worst on 03-OCT-2006. Unspecified medical attention was sought. No lab studies were performed. On 10-OCT-2006 the patient felt better but still had soreness at the injection site. On 06-NOV-2006 the patient overal felt better, but still had a little redness at the injection site. Subsequently the patient recovered. It was also noted that it had been 13 years since the patient's last vaccination with Pneumovax 23. No product quality complaint was involved. No further information is expected.
I don't seem to have much adverse events that day or the following days. It was about a week later that I had an inflammatory flare on both of my arms. It was all red, inflamed and had little red dots all over. That was the start of whatever it is that I still have today. I went to (urgent care) on 3/21/2021 and they prescribed a topical antibiotic because by then it was all over my body and they prescribed a topical steroid as well. They referred me to a dermatologist. I saw the dermatologist on 3/24/2021 and he said to continue the topical antibiotic as well as a highly potent steroid which I did not take due to not wanting to take it prior to getting the second vaccine. I also did some lab work. 3/31/2021 I got the second dose of the Moderna. I saw the dermatologist again on 4/8/2021. I wasn't getting any results so I saw another dermatologist  on 4/24/2021. That dermatologist didn't give me a diagnosis but did do a biopsy.
Left arm discomfort 3 days after injection. Pain radiating from lt arm to lt forearm. Ibuprofen 200mg started 3/2/2006 with decrease intensity of symptom.
excursion from the freezer/administered to 118 patients(25Oct2021- 49 given ); This spontaneous case was reported by a nurse and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (excursion from the freezer/administered to 118 patients(25Oct2021- 49 given )) in a 64-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 939901) for COVID-19 vaccination.     No Medical History information was reported.    On 25-Oct-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Oct-2021, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (excursion from the freezer/administered to 118 patients(25Oct2021- 49 given )). On 25-Oct-2021, PRODUCT TEMPERATURE EXCURSION ISSUE (excursion from the freezer/administered to 118 patients(25Oct2021- 49 given )) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter. Treatment information was not provided.   Most recent FOLLOW-UP information incorporated above includes: On 15-Nov-2021: Additional information contain included patient  and suspect details
Myalgia, NauseaVomiting, Nasal congestion Narrative:
sneezing, low fever 99-100, severe muscle ache-neck & arms, calves of legs as compared to prev;diarrhea;